Alzheimer’s Disease Treatment: The Search for a Breakthrough
As the search for modalities to cure Alzheimer’s disease (AD) has made slow progress, research has now turned to innovative pathways involving neural and peripheral inflammation and neuro-regeneration. Widely used AD treatments provide only symptomatic relief without changing the disease course. The...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-06-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/59/6/1084 |
| _version_ | 1797593573036654592 |
|---|---|
| author | Allison B. Reiss Dalia Muhieddine Berlin Jacob Michael Mesbah Aaron Pinkhasov Irving H. Gomolin Mark M. Stecker Thomas Wisniewski Joshua De Leon |
| author_facet | Allison B. Reiss Dalia Muhieddine Berlin Jacob Michael Mesbah Aaron Pinkhasov Irving H. Gomolin Mark M. Stecker Thomas Wisniewski Joshua De Leon |
| author_sort | Allison B. Reiss |
| collection | DOAJ |
| description | As the search for modalities to cure Alzheimer’s disease (AD) has made slow progress, research has now turned to innovative pathways involving neural and peripheral inflammation and neuro-regeneration. Widely used AD treatments provide only symptomatic relief without changing the disease course. The recently FDA-approved anti-amyloid drugs, aducanumab and lecanemab, have demonstrated unclear real-world efficacy with a substantial side effect profile. Interest is growing in targeting the early stages of AD before irreversible pathologic changes so that cognitive function and neuronal viability can be preserved. Neuroinflammation is a fundamental feature of AD that involves complex relationships among cerebral immune cells and pro-inflammatory cytokines, which could be altered pharmacologically by AD therapy. Here, we provide an overview of the manipulations attempted in pre-clinical experiments. These include inhibition of microglial receptors, attenuation of inflammation and enhancement of toxin-clearing autophagy. In addition, modulation of the microbiome-brain-gut axis, dietary changes, and increased mental and physical exercise are under evaluation as ways to optimize brain health. As the scientific and medical communities work together, new solutions may be on the horizon to slow or halt AD progression. |
| first_indexed | 2024-03-11T02:11:13Z |
| format | Article |
| id | doaj.art-47c3169ae4524ad1a119aa0bb9fa7c57 |
| institution | Directory Open Access Journal |
| issn | 1010-660X 1648-9144 |
| language | English |
| last_indexed | 2024-03-11T02:11:13Z |
| publishDate | 2023-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-47c3169ae4524ad1a119aa0bb9fa7c572023-11-18T11:31:13ZengMDPI AGMedicina1010-660X1648-91442023-06-01596108410.3390/medicina59061084Alzheimer’s Disease Treatment: The Search for a BreakthroughAllison B. Reiss0Dalia Muhieddine1Berlin Jacob2Michael Mesbah3Aaron Pinkhasov4Irving H. Gomolin5Mark M. Stecker6Thomas Wisniewski7Joshua De Leon8Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USADepartment of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USADepartment of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USADepartment of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USADepartment of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USADepartment of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USAFresno Institute of Neuroscience, Fresno, CA 93730, USACenter for Cognitive Neurology, Departments of Neurology, Pathology and Psychiatry, NYU School of Medicine, New York, NY 10016, USADepartment of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USAAs the search for modalities to cure Alzheimer’s disease (AD) has made slow progress, research has now turned to innovative pathways involving neural and peripheral inflammation and neuro-regeneration. Widely used AD treatments provide only symptomatic relief without changing the disease course. The recently FDA-approved anti-amyloid drugs, aducanumab and lecanemab, have demonstrated unclear real-world efficacy with a substantial side effect profile. Interest is growing in targeting the early stages of AD before irreversible pathologic changes so that cognitive function and neuronal viability can be preserved. Neuroinflammation is a fundamental feature of AD that involves complex relationships among cerebral immune cells and pro-inflammatory cytokines, which could be altered pharmacologically by AD therapy. Here, we provide an overview of the manipulations attempted in pre-clinical experiments. These include inhibition of microglial receptors, attenuation of inflammation and enhancement of toxin-clearing autophagy. In addition, modulation of the microbiome-brain-gut axis, dietary changes, and increased mental and physical exercise are under evaluation as ways to optimize brain health. As the scientific and medical communities work together, new solutions may be on the horizon to slow or halt AD progression.https://www.mdpi.com/1648-9144/59/6/1084Alzheimer’s diseaseamyloidinflammationdementiadrug therapydiet |
| spellingShingle | Allison B. Reiss Dalia Muhieddine Berlin Jacob Michael Mesbah Aaron Pinkhasov Irving H. Gomolin Mark M. Stecker Thomas Wisniewski Joshua De Leon Alzheimer’s Disease Treatment: The Search for a Breakthrough Medicina Alzheimer’s disease amyloid inflammation dementia drug therapy diet |
| title | Alzheimer’s Disease Treatment: The Search for a Breakthrough |
| title_full | Alzheimer’s Disease Treatment: The Search for a Breakthrough |
| title_fullStr | Alzheimer’s Disease Treatment: The Search for a Breakthrough |
| title_full_unstemmed | Alzheimer’s Disease Treatment: The Search for a Breakthrough |
| title_short | Alzheimer’s Disease Treatment: The Search for a Breakthrough |
| title_sort | alzheimer s disease treatment the search for a breakthrough |
| topic | Alzheimer’s disease amyloid inflammation dementia drug therapy diet |
| url | https://www.mdpi.com/1648-9144/59/6/1084 |
| work_keys_str_mv | AT allisonbreiss alzheimersdiseasetreatmentthesearchforabreakthrough AT daliamuhieddine alzheimersdiseasetreatmentthesearchforabreakthrough AT berlinjacob alzheimersdiseasetreatmentthesearchforabreakthrough AT michaelmesbah alzheimersdiseasetreatmentthesearchforabreakthrough AT aaronpinkhasov alzheimersdiseasetreatmentthesearchforabreakthrough AT irvinghgomolin alzheimersdiseasetreatmentthesearchforabreakthrough AT markmstecker alzheimersdiseasetreatmentthesearchforabreakthrough AT thomaswisniewski alzheimersdiseasetreatmentthesearchforabreakthrough AT joshuadeleon alzheimersdiseasetreatmentthesearchforabreakthrough |